Literature DB >> 2061928

Isoprenyl phosphinylformates: new inhibitors of squalene synthetase.

S A Biller1, C Forster, E M Gordon, T Harrity, L C Rich, J Marretta, C P Ciosek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2061928     DOI： 10.1021/jm00110a024

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  5 in total

1.  RPR 101821, a new potent cholesterol-lowering agent: inhibition of squalene synthase and 7-dehydrocholesterol reductase.

Authors:  D Amin; R Z Rutledge; S J Needle; D J Hele; K Neuenswander; R C Bush; G E Bilder; M H Perrone
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

2.  Covalent Guanosine Mimetic Inhibitors of G12C KRAS.

Authors:  Yuan Xiong; Jia Lu; John Hunter; Lianbo Li; David Scott; Hwan Geun Choi; Sang Min Lim; Anuj Manandhar; Sudershan Gondi; Taebo Sim; Kenneth D Westover; Nathanael S Gray
Journal:  ACS Med Chem Lett       Date:  2016-11-30       Impact factor: 4.345

3.  Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase.

Authors:  J D Bergstrom; M M Kurtz; D J Rew; A M Amend; J D Karkas; R G Bostedor; V S Bansal; C Dufresne; F L VanMiddlesworth; O D Hensens
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

Review 4.  Roles of Farnesyl-Diphosphate Farnesyltransferase 1 in Tumour and Tumour Microenvironments.

Authors:  Nguyen Thi Ha; Chang Hoon Lee
Journal:  Cells       Date:  2020-10-25       Impact factor: 6.600

Review 5.  Human isoprenoid synthase enzymes as therapeutic targets.

Authors:  Jaeok Park; Alexios N Matralis; Albert M Berghuis; Youla S Tsantrizos
Journal:  Front Chem       Date:  2014-07-22       Impact factor: 5.221
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.